Your browser is no longer supported. Please, upgrade your browser.
VAPO Vapotherm, Inc. daily Stock Chart
Vapotherm, Inc.
Index- P/E- EPS (ttm)-2.76 Insider Own6.00% Shs Outstand17.47M Perf Week8.25%
Market Cap364.60M Forward P/E- EPS next Y-2.78 Insider Trans- Shs Float11.36M Perf Month25.42%
Income-46.50M PEG- EPS next Q-0.80 Inst Own74.40% Short Float1.75% Perf Quarter5.72%
Sales43.90M P/S8.31 EPS this Y-35.90% Inst Trans2.30% Short Ratio5.55 Perf Half Y18.58%
Book/sh2.42 P/B8.62 EPS next Y10.60% ROA-66.00% Target Price26.33 Perf Year-
Cash/sh3.25 P/C6.43 EPS next 5Y46.70% ROE88.70% 52W Range14.70 - 22.29 Perf YTD4.61%
Dividend- P/FCF- EPS past 5Y- ROI-46.50% 52W High-6.37% Beta-
Dividend %- Quick Ratio5.30 Sales past 5Y- Gross Margin40.30% 52W Low41.97% ATR1.11
Employees276 Current Ratio6.30 Sales Q/Q15.00% Oper. Margin-99.50% RSI (14)67.45 Volatility7.03% 5.73%
OptionableNo Debt/Eq1.11 EPS Q/Q-43.00% Profit Margin- Rel Volume2.43 Prev Close20.53
ShortableYes LT Debt/Eq1.01 EarningsMay 07 AMC Payout- Avg Volume35.80K Price20.87
Recom1.00 SMA2015.87% SMA5016.48% SMA20015.86% Volume86,897 Change1.66%
Dec-10-18Initiated William Blair Outperform
Dec-10-18Initiated Canaccord Genuity Buy $25
Dec-10-18Initiated BofA/Merrill Buy $26
May-24-19 04:30PM  Vapotherm to Present at the William Blair 39th Annual Growth Stock Conference Business Wire
May-14-19 11:55PM  Vapotherm Inc (VAPO) Q1 2019 Earnings Call Transcript Motley Fool
May-10-19 05:01PM  Vapotherm to Present at the Bank of America Merrill Lynch 2019 Health Care Conference Business Wire
May-07-19 05:17PM  Vapotherm: 1Q Earnings Snapshot Associated Press
04:01PM  Vapotherm Reports First Quarter 2019 Financial Results Business Wire
Apr-29-19 12:51PM  You Might Like Vapotherm, Inc. (NYSE:VAPO) But Do You Like Its Debt? Simply Wall St.
Apr-17-19 07:30AM  Vapotherm to Report First Quarter 2019 Financial Results Business Wire
Mar-26-19 07:30AM  Emergency Department Subgroup Study Showed Hi-VNI® Technology Had Similar Outcomes to Non-invasive Positive Pressure Ventilation in Management of Respiratory Distress Among Acute Decompensated Heart Failure Patients Business Wire
Mar-22-19 05:48PM  Vapotherm Inc (VAPO) Files 10-K for the Fiscal Year Ended on December 31, 2018 -9.74%
Mar-12-19 05:44PM  Vapotherm: 4Q Earnings Snapshot Associated Press
04:13PM  Vapotherm Reports Fourth Quarter and Fiscal Year 2018 Financial Results Business Wire
02:30PM  Vapotherm, Inc. to Host Earnings Call ACCESSWIRE
Feb-13-19 07:30AM  Vapotherm® Releases Next Generation of Capital Unit: Precision Flow Hi-VNI System Business Wire
Dec-24-18 07:30AM  Vapotherm to be Added to the Russell 2000®, 3000® and Microcap® Indexes Business Wire
Dec-04-18 08:00AM  Clinical Study Shows Vapotherms New IntellO2 Module for Precision Flow® System Significantly Improves Maintenance of Premature Neonates in Target Oxygenation Range Business Wire
Nov-16-18 11:58AM  Vapotherm Announces Closing of Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares Business Wire
Nov-14-18 11:08AM  Vapotherm shares soar 8.5% in trading debut MarketWatch
06:58AM  Vapotherm sells 4 million shares priced at $14 each in IPO to raise $56 million MarketWatch
Nov-13-18 08:48PM  Vapotherm Announces Pricing of Initial Public Offering Business Wire
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that use Hi-VNI technology to deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit and Q50 compressor; and disposable products comprising single-use disposables and nasal interfaces. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.